Denosumab reduced RR of fracture vs alendronate across fracture types, eg, by 36% for hip fracture, by 43% for nonvertebral fractures, and by 30% for vertebral fractures.
Tirzepatide delivers 15.7% weight loss in adults with obesity; remote intervention increases cancer screening in women; women at greater post-MI risk vs men; plus 2 more updates of note.
Significant decreases were observed in bone strength and mean and trabecular BMD 12 months after sleeve gastrectomy in patients aged 13 to 25 years, a new study reveals.